Business Context and Reporting Period
Jackson Acquisition Company II, a Cayman Islands-based emerging growth company, filed this Form 8-K on December 11, 2024, to report the consummation of its initial public offering (IPO). The company is incorporated in the Cayman Islands with principal executive offices in Alpharetta, Georgia.
Key Financial Metrics
- Gross Proceeds from IPO: $230,000,000 from the sale of 23,000,000 Units (including full exercise of the over-allotment option) at $10.00 per Unit.
- Gross Proceeds from Private Placement: $8,400,000 from the sale of 840,000 Private Placement Units at $10.00 per Unit.
- Total Funds in Trust: $232,300,000 placed in a segregated trust account with Continental Stock Transfer & Trust Company.
- Capital Structure: Each Unit consists of one Class A ordinary share and one right to acquire one-tenth (1/10) of one Class A ordinary share.
Material Changes
This filing represents the company's initial capitalization event. Prior to December 11, 2024, the company had not generated operating revenue or held the reported cash balances. The material change is the transition from a pre-IPO entity to a publicly traded SPAC with $232.3 million in trust assets.
Outlook, Risks, and Contingencies
- Private Placement Restrictions: Private Placement Units are subject to transfer restrictions until 30 days following the consummation of the company's initial business combination.
- Trust Account: Proceeds are held in a segregated trust account pending a future business combination.
- Financial Statements: An audited balance sheet as of December 11, 2024, reflecting these proceeds is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the full exercise of the 3,000,000 Unit over-allotment option.
- Confirm the identity of private placement purchasers (RJ Healthcare SPAC II, LLC and Roth Capital Partners, LLC).
- Review Exhibit 99.1 for the audited balance sheet confirming the $232,300,000 trust balance.
- Check the transfer restriction terms for the Private Placement Units.